Six interdisciplinary teams of AIDS investigators received initial awards totaling more than $6 million last month in the launch of a novel effort sponsored by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The money represents the first of four years of funding the scientists will receive through the new Strategic Program for Innovative Research on AIDS Treatment (SPIRAT). SPIRAT will support an array of experimental strategies to counter HIV infection and restore immune response, including gene therapy and DNA-based therapeutic vaccines. The six principal investigators receiving grants are: Philip Greenberg, Fred Hutchinson Cancer Research Center, Seattle; Judy Lieberman, New England Medical Center, Boston; Thomas Merigan, Stanford University, Stanford, Calif.; Gary Nabel, University of Michigan, Ann Arbor; Flossie Wong-Staal, University of California, San Diego; and David Weiner, University of Pennsylvania, Philadelphia.

Women in technical fields have historically had a more difficult time starting and then advancing...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?